News

LTS and Nualtis Announce Strategic Cooperation to Expand Global Manufacturing Capabilities, Accelerate Market Expansion, and Ensure Customer Success
LTS LOHMANN Therapie-Systeme AG (LTS), a leading pharmaceutical technology company, and Nualtis (formerly IntelGenx Corp.), an innovator in ...
VCCircle8d
Evera Cabs, Fantail, Skippi, Innovodigm, Kruu raise funding
Electric cab provider Evera Cabs, ice pop brand Skippi, B2B textile startup Fantail, skilling platform Kruu and medtech ...
Nasdaq23d
Medicus Pharma Ltd. Announces Submission of Product Development Plan to the Food and Drug Administration (FDA) to Treat External Squamous Cell Carcinoma (SCC) in Horses - Nasdaq
Doxorubicin-containing microneedle array (D-MNA) is a patent protected dissovable transdermal patch with cellulose based microneedle arrays that are tip-loaded with doxorubicin.
Yahoo Finance2d
Medicus Pharma Ltd. (MDCX)
Company Is Advancing Use of Novel Doxorubicin-containing Microneedle Array (D-MNA) Patch in Veterinary Oncology as an Orphan Drug Philadelphia, Pennsylvania-- (Newsfile Corp. - June 9, 2025 ...
Innovodigm, AuraML, Sthyr Energy Secure Early-Stage Funding for Growth
IAN Leads INR 5.5 Cr Funding in Med-tech Innovodigm Kolkata-based med-tech startup Innovodigm has raised INR 5.5 crore in a seed funding round led by the IAN Group, which contributed INR 4.5 crore, ...
Inc4212d
How Conscious Chemist Plans To Build An INR 100 Cr Brand With Active-First Skincare
Conscious Chemist challenges India’s ‘natural is good’ skincare narrative with science-backed clinically proven formulations ...
The Lancet12d
Microneedle array delivered recombinant coronavirus vaccines: Immunogenicity and rapid translational development - eBioMedicine - The Lancet
These studies demonstrate the rapid development and immunogenicity of novel microneedle array (MNA) delivered recombinant coronavirus (SARS-CoV-2) vaccines. MNA delivered MERS-S1 subunit vaccines ...
AlphaGalileo5d
Formulation approaches and strategies for transdermal delivery of insulin: special emphasis on microneedle-based systems
Disclaimer: AlphaGalileo is not responsible for the accuracy of content posted to AlphaGalileo by contributing institutions or for the use of any information through the AlphaGalileo system.